logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11236045 B1

PDFFull Text
Date of Patent:
Feb. 01, 2022

Filed:

Jun. 08, 2018

Substituted sulfoximine compounds

Applicant:

Cadila Healthcare Limited, Gujarat, IN;

Inventors:

Rajiv Sharma, Ahmedabad, IN;

Pravin Iyer, Ahmedabad, IN;

Sameer Agarwal, Ahmedabad, IN;

Assignee:

Cadila Healthcare Limited, Ahmedabad, IN;

Attorney:

IpHorgan Ltd.

Primary Examiner:

Amanda L Aguirre

Int. Cl.
CPC ...
C07C 381/10 (2006.01); C07D 213/71 (2006.01); C07D 213/76 (2006.01); C07D 215/36 (2006.01); C07D 231/38 (2006.01); C07D 265/30 (2006.01); C07D 305/08 (2006.01); C07D 307/64 (2006.01); C07D 319/16 (2006.01); C07D 333/34 (2006.01); A61P 29/00 (2006.01); A61K 31/4406 (2006.01);
U.S. Cl.
CPC ...
C07C 381/10 (2013.01); A61K 31/4406 (2013.01); A61P 29/00 (2018.01); C07D 213/71 (2013.01); C07D 213/76 (2013.01); C07D 215/36 (2013.01); C07D 231/38 (2013.01); C07D 265/30 (2013.01); C07D 305/08 (2013.01); C07D 307/64 (2013.01); C07D 319/16 (2013.01); C07D 333/34 (2013.01);
Abstract

The present invention relates to novel heterocyclic compounds of the general formula (I) their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers and polymorphs. The invention also relates to processes for the preparation of the compounds of invention, pharmaceutical compositions containing the compounds and their use as the compounds of the invention belong to the family of NOD-like receptor family (NLR) protein NLRP3 modulators. The present invention thus relates to novel NLRP3 modulators as well as to the use of the novel inhibitor compounds in the treatment of diseases or conditions as well as treatment of disease states mediated by NLRP3 as well as treatment of diseases or conditions in which interleukin 1β activity and interleukin-18 (IL-18) is implicated.

Find Patent Forward Citations

Sharma, Rajiv. (2022). Substituted sulfoximine compounds (U.S. Patent No. 11236045). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11236045

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…